Can Europe accelerate out of trouble

Article Abstract:

Biotech firms of Europe should adopt the incubator concept or accelerators that provide customizable laboratory and business space for young companies and eventually help biotech companies, come out of the arrested development. Accelerator not only backs companies in addressing various slow steps in the healthcare product development process but also focus on particular areas of clinical practice.

Forecasts, trends, outlooks, Industry forecasts

---

The rise of European venture capital for biotechnology

Article Abstract:

This article discusses biotechnology industry growth surge in Europe fueled by changes in economic institutions, entrepreneurial climate, and venture capital funds availability. Europe's shares in the global public and private companies are 17% and 48%, respectively as of 2002.

United States, Government domestic functions, Financial management, Europe, Company investment, Investments, Science and technology policy, Venture capital

---

Superscience me!

Article Abstract:

Massachusetts and California are the major centers for biotech economic power with the supercluster, an aggregate of world-class science, talent, mentor and established biotech firms designed as a superscience which shows a lead in biotech.

California, Massachusetts

Similar abstracts:

• Abstracts: Life-line out of troubles. Getting a fix on the MBO position. The growth factor
• Abstracts: A quick word about Coca-Cola. PepsiCo Inc. Coca-Cola Co
• Abstracts: European economic integration and the consequences for US agriculture. Economic impact of proper diets on farm and marketing resources
• Abstracts: Dotcom mania: the rise and fall of internet stock prices. Rumors
• Abstracts: What if trading location is different from business location? Evidence from the Jardine Group

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.